Leidos' Hart-Scott-Rodino Act waiting period expires

Leidos Holdings, Inc. said the waiting period mandated for United States government antitrust review of proposed transactions under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 in connection with the combination of Leidos with Lockheed Martin´s realigned Information Systems & Global Solutions business (IS&GS) in a Reverse Morris Trust transaction.

Expiration of the waiting period under the HSR Act satisfies one of the conditions necessary for the combination. The proposed transaction remains subject to approval by the shareholders of Leidos, as well as certain other regulatory approvals and customary closing conditions.

Leidos is a science and technology solutions leader working to address some of the world´s toughest challenges in national security, health and infrastructure. The company´s 18,000 employees support vital missions for government and the commercial sector, develop innovative solutions to drive better outcomes and defend our digital and physical infrastructure from ´new world´ threats. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately USD5.09 billion for the twelve months ended January 1, 2016.